Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06516575 · ClinicalTrials.gov registry record · NA
Listening Effort in Cochlear Implant Users
A NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 1
- Study location
NCT06516575: Recruiting NA study of Hearing Loss and Hearing Loss, Sensorineural, sponsored by University of Minnesota.
NCT06516575 is a NA study of Hearing Loss and Hearing Loss, Sensorineural that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 450 participants, below the 6,113-participant average among 58 other Hearing Loss trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06516575, a NA study of Hearing Loss and Hearing Loss, Sensorineural, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
People with hearing loss experience extra effort when listening, which can lead to severe psychological barriers to communication and social participation. Listening effort can lead to fatigue, mental strain, burnout, medical sick leave, and the need for increased time to recover from regular daily activities. This proposal aims to understand effort changes on a moment-to-moment basis during listening, how long the effort lasts, and how the planning and execution of effort is impacted by the experience of using a cochlear implant.
Primary Outcome
Listening effort is inferred by measuring changes in pupil dilation linked to stimulus landmarks, as well as changes in microsaccade rate and blinks
Conditions Studied
Interventions
- BEHAVIORAL sentence manipulations
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06516575 shows while recruiting
NCT06516575 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 6,113-participant average among 58 other Hearing Loss trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which sentence manipulations is the first listed.
NCT06516575 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06516575 about?
NCT06516575 is a clinical study titled "Listening Effort in Cochlear Implant Users". People with hearing loss experience extra effort when listening, which can lead to severe psychological barriers to communication and social participation. Listening effort can lead to fatigue, mental strain, burnout, medical sick leave, and the need for increased time to recover from regular daily ...
What is the current status of trial NCT06516575?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2023-09-01. Estimated completion is 2028-08-31.
What conditions does trial NCT06516575 study?
This clinical trial studies the following conditions: Hearing Loss, Hearing Loss, Sensorineural, Auditory Perception; Abnormal.
What interventions are being tested in trial NCT06516575?
The interventions under investigation include: sentence manipulations (BEHAVIORAL).
Who is sponsoring clinical trial NCT06516575?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06516575 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06516575's enrollment target sits among peer trials
450 17th of 58 higher than 42 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI